Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

October 15, 2021

HEMATOPOIETIC CELL TRANSPLANTATION IS FEASIBLE IN PATIENTS WITH PRIOR COVID-19 INFECTION.

Transplantation and Cellular Therapy
Nishi ShahBoglarka Gyurkocza
October 11, 2021
Review
Open Access

Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies.

Frontiers in Oncology
Deeksha Mehtani, Niti Puri
October 9, 2021

Chronic Lymphocytic Leukemia (CLL): Biology and Therapy.

Cancer Treatment and Research
Tanya Siddiqi
October 8, 2021

The Relevance of Additional Immunohistochemical Markers on the Differential Diagnosis of Small B-Cell Lymphomas: A Case-control Study.

Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
Hale KıvrakIşınsu Kuzu
October 5, 2021

Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Mahsa KhanlariShaoying Li
September 29, 2021
Review
Open Access

BH3 Mimetics in Hematologic Malignancies.

International Journal of Molecular Sciences
Pavel KlenerLadislav Andera
September 27, 2021
Case Report
Open Access

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.

Frontiers in Oncology
Valerio GuarentePaolo Sportoletti
September 23, 2021

Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.

Cancer Reports
Ryota ShiraiMotohiro Kato
September 22, 2021

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies.

Blood Advances
Matthew S DavidsIan W Flinn
September 14, 2021
Case Report

Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.

Journal of Clinical and Experimental Hematopathology : JCEH
Yuta TsuyukiAyako Sakakibara
September 9, 2021

[Molecular pathogenesis and treatment of chronic lymphocytic leukemia].

[Rinshō ketsueki] The Japanese journal of clinical hematology
Ritsuro Suzuki
August 30, 2021
Case Report

HTLV-1 infection in acute t- lymphocytic leukemia/lymphoma.

Autopsy & Case Reports
Mohammad BarouqaYanhua Wang
August 25, 2021

Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype: 1950-1994.

Blood
Megumu FujiharaKiyohiko Mabuchi
August 20, 2021

Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine-19 MRI.

NMR in Biomedicine
Lawrence M LechugaSean B Fain
August 17, 2021
Open Access

Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies.

Cancer & Metabolism
Daniel F LiefwalkerRosalie C Sears

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/composite-lymphoma/5e8837c3-71fb-4d3b-bb67-f2f9467e3479